Esophageal cancer-related gene 4 (Ecrg4), a hormone-like peptide, is thought to be a tumor suppressor, however little is known about the mechanism of how Ecrg4 suppresses tumorigenesis. Here we show that the ecrg4 null glioma-initiating cell (GIC) line, which was generated from neural stem cells of ecrg4 knockout ( 
Introduction
Tumors are caused by the accumulation of genetic and epigenetic mutations in genes called tumor suppressor genes and proto-oncogenes that normally function as regulators of cell proliferation.
In addition to tumors themselves, their surrounding microenvironment, which is composed by extracellular matrix and several types of cells including immune cells, endothelial cells and fibroblasts, has a role to either promote or inhibit tumor growth (1) . However, it still remains elusive how genetic and epigenetic mutations in tumor cells influence the surrounding cells.
Esophageal cancer-related gene 4 (Ecrg4), also known as chromosome 2 ORF 40 (C2orf40) and Augurin, was originally identified as one of the genes whose expression decreased in human squamous esophageal cell carcinomas, compared with their surrounding non-tumor cells (2) . Thereafter, it has been reported that ecrg4 expression was downregulated in various types of tumors such as colorectal cancer, glioma, prostate cancer and breast cancer because of hypermethylation of its promoter (3) (4) (5) (6) . Moreover, several papers have shown the growth inhibitory effect of Ecrg4 when overexpressed in cancer cell lines (7) (8) (9) . Together, these findings suggested Ecrg4 6 as a tumor suppressor.
Unlike other commonly studied tumor suppressor genes, ecrg4 encodes a peptide hormone-like protein, and is thought to function on cell surface and/or in extracellular fluid (10) (11) (12) (13) . It was demonstrated that Ecrg4 was first produced as a precursor protein of 148 amino acids, and then was proteolytically processed into several different fragments (10) (11) (12) (13) . Therefore, the cleaved Ecrg4 fragment(s) seems likely to transmit growth retardation signals into the cells in an autocrine/paracrine manner, rather than Ecrg4 directly inhibits cell proliferation machinery in the cells.
Using the mouse glioma-initiating cell (GIC) models (14, 15) , we addressed how Ecrg4 acts as a tumor suppressor in vivo. Unexpectedly, we found that Ecrg4 from GICs, rather than tumor-surrounding cells, was essential for its tumor-suppressor function. Ecrg4 directly induced the expression of pro-inflammatory factors, including tumor necrosis factor α (TNFα) and type-I interferon (IFN), in microglia, an innate immune cell in central nervous system. Among the factors, we demonstrate that the activation of type-I IFN signaling pathway was indispensable for GIC elimination in vivo. Together, our findings identified Ecrg4 as a novel immunosurveillance activator.
Results

Ecrg4-deficient increased GIC tumorigenesis in vivo
We first addressed whether Ecrg4 functions as a tumor suppressor in our mouse GIC model. We established a set of GIC lines by overexpressing sv40LT and hrasL61 in mouse embryonic neural stem cells (NSCs) from ecrg4 heterozygous intercrosses, as shown previously (15) . GIC(+/+) from ecrg4 +/+ NSCs clearly expressed ecrg4, whereas its expression level decreased in GIC(+/-) from ecrg4 +/-NSCs and was undetectable in GIC(-/-) from ecrg4 -/-ones (Fig. 1A) . There was little difference in cell proliferation and colony formation in soft agar between three lines ( Fig. 1B and 1C ). In addition, overexpression of ecrg4 did not induce cell cycle arrest in any of GIC lines (data not shown). Nonetheless, we found that GIC(-/-) killed nude mice faster than other GICs, although all GIC lines formed tumors when transplanted into the brains ( Fig. 1D and   1E ). These data indicated that Ecrg4 did not inhibit GIC proliferation.
Ecrg4
-/-GICs showed more malignant phenotypes in wild type mice than in nude ones
To further examine the function of Ecrg4 in tumorigenesis, we transplanted GIC(+/+) and GIC(-/-) into brains of syngenic wild type (WT) mice. Strikingly, we observed that GIC(-/-) killed all mice within 1 month, whereas GIC(+/+) did only a couple of mice out of eleven by 4 months (Fig. 2A) . Together with a data that both type of GICs formed tumors in brain of nude mice ( Fig. 1D and 1E ), these suggested that Ecrg4 stimulated anti-tumor activity of immune system. It should be noted that tumors formed in WT mice showed more aggressive phenotypes than those in nude mice (Fig. 1E , 2B and 2C), and closely resembled to human glioblastoma (GBM), the most malignant type of glioma, with massive hemorrhage, pleomorphism, multinuclear giant cells, mitosis and necrosis ( Fig. 2C) , suggesting the critical role of immune system for tumor malignancy.
Since Ecrg4 secreted from the tumor-surrounding cells is thought to prevent tumorigenesis as a tumor-suppressor, we examined the tumorigenicity of both GIC(+/+) and GIC(-/-) in the ecrg4 -/-brains. GIC(+/+) and GIC(-/-) formed tumors in both brains and kill mice in a similar way ( Supplementary Fig. 1 ), suggesting that Ecrg4 from tumor-surrounding cells does not act as a tumor-suppressor in our brain tumor model.
Ecrg4 stimulated immune responses
We checked which leukocytes were infiltrated into tumor-bearing brains 2 weeks after implantation of GICs, a time point that almost all mice were alive, by flow cytometry.
Transplantation of GIC(+/+) and GIC(-/-) increased number of all immune cells examined, CD8 + , CD4 + , NK, CD11c + and B cells, compared with the injection of medium alone (control). CD11c + cells increased slightly by GIC(+/+) transplantation compared with GIC(-/-) one, however there were no clear differences in cell population between GIC(+/+) and GIC(-/-) injections (Fig. 3A) .
To identify which cytotoxic immune cells were involved in the GIC(+/+) elimination, we performed cell depletion experiments using specific monoclonal antibodies ( 2 ). Among the commonly up-regulated genes, we noticed that the expression of many pro-inflammatory cytokines, including interleukin 1 (il1), il6, il12 p40 subunit and tnfα, and chemokines strongly increased in the presence of Ecrg4 fragments (Fig. 4A) . We confirmed the increased expression of key pro-inflammatory factors, il6, il12 p40 subunit and tnfα, and a type-I IFN ifnβ, which activates critical components of the innate and adaptive immune systems underlying cancer immunosurveillance (18, 19) , in the Ecrg4 fragment-treated microglia (Fig. 4B ).
We further evaluated the secretion of candidate cytokines and chemokines using the multiplex cytokine assay; both Ecrg4(71-132) and Ecrg4(133-148) fragments induced secretion of IL1β, IL12 p40 subunit, TNFα, IL6, granulocyte colony stimulation factor (GCSF), C-X-C motif chemokine ligand 1 (CXCL1) and C-C motif chemokine ligand 5 Supplementary Fig. 3 ). Notably, the induction of pro-inflammatory cytokines and chemokines in microglia by Ecrg4(71-132) was much stronger than that by Ecrg4(133-148), although both Ecrg4 fragments similarly induced the expression of many pro-inflammatory cytokines and chemokines.
Ecrg4 prevented GIC tumorigenesis through the activation of type-I IFN signaling
Production of IL12 p40 subunit and TNFα by microglia has been shown to contribute to both innate and adoptive anti-tumor immunity (20, 21) . We therefore examined their roles in our GIC transplantation model. Using anti-IL12 p40 subunit and TNFα depletion antibodies, we found that neither factors had apparent effects on GIC elimination (Fig. 5A ).
Since Ecrg4 fragments enhanced the expression of ifnβ mRNA in microglia in vitro ( Fig. 4A and 4B Here we showed that ecrg4-deficient GICs, GIC(-/-), formed tumors in brains of WT mice whereas ergc4-expressing GICs, GIC(+/+), were frequently eliminated, although both types of GICs similarly formed tumors in nude mouse brains, suggesting that tumor suppression was exerted more by immunosurveillance than simple growth inhibition.
We demonstrated that this tumor suppression was dependent on the Ecrg4-induced activation of type-I IFN signaling pathway, which functions for immunosurveillance and tumor elimination (23) (24) (25) (26) (27) . We also revealed that Ecrg4 induced secretion of many pro-inflammatory cytokines, including IFNβ, IL6 and TNFα, and chemokines from primary microglia in culture. To generalize the potential of Ecrg4/type-I IFN pathway axis as a therapeutic target in GBM, we have checked the expression of both ecrg4 and type-I ifns in human GBM and LGG using the Cancer Genome Atlas (TCGA) analysis (http://cancergenome.nih.gov), and found that the expression of Ecrg4 and type-I IFNs, α5, α14 and β1, significantly decreased in GBM compared with lower-grade glioma (LGG) ( Supplementary Fig.4 ). These data support our findings that the Ecrg4/type-I IFN pathway axis prevents GBM, although it is difficult to investigate their relationship directly in human. In addition, it may need to evaluate our findings using other glioma models. Altogether, we concluded Ecrg4 as an important danger-alerting factor, which activates the immune cells to eradicate tumor. 
Materials and Methods
Animals
Ecrg4 KO mice were established by conventional gene targeting procedures at RIKEN CDB. The detailed characterization of Ecrg4 KO mice will be reported elsewhere.
Heterozygotes were then backcrossed to C57BL/6 mice for at least eight generations.
C57BL/6-background Stat1 -/-mice were described previously (32) . Balb/c nude and C57BL/6 mice were purchased from Charles River Japan and CLEA Japan. All mouse experiments were performed following the protocols approved by the Animal Care and Use Committee of Ehime University and Hokkaido University.
Plasmids and chemicals
pCMS-EGFP-H-Ras
L61 and pBabe-Puro-SV40LT were previously described (15) . The 
Establishment of mouse GIC lines and Cell culture
Mouse model of GIC lines were generated as previously described (14, 15) . Briefly, NSCs were prepared from embryonic day 14.5 mouse telencephalon and expanded in DMEM/F12 (Wako, Japan) supplemented with chemicals, bFGF (10 ng/ml), and EGF (10 ng/ml) as described previously (14) . Then, cells were first transfected with pBabe-Puro-SV40LT vector, followed with pCMS-EGFP-HRas 
Soft agar assay
The procedure has been described previously (14, 15) . Briefly, the cells were suspended in 0.3% top agar and layered onto 0.6% bottom agar. After the top agar solidified, culture medium was added and the cells were cultured for 20 days with medium changes every 3 days.
Intracranial cell transplantation and histopathology
Indicated number of cells was suspended in 3 µl of HBSS and injected into brains of 6~8 week-old female mice that had been anesthetized with 10% pentobarbital as described previously (14, 15) . When transplanted into WT mice, 10 times more GICs were used than those in nude mice. For histopathology, the dissected mouse brains were fixed in 4% paraformaldehyde at 4°C overnight, dehydrated and embedded in paraffin.
Sections (10 μm thick) were rehydrated, and stained with hematoxylin-eosin (HE) using standard techniques.
Brain infiltrating leukocyte (BIL) isolation
The procedure has been described previously (34) . Briefly, brain tissues were mechanically minced, resuspended in 70% Percoll (GE), overlaid with 37% and 30%
Percoll, and centrifuged for 20 min at 500 × g.
Depletion antibodies
IFNAR1 (clone MAR1-5A3), TNFα (clone MP6-XT22), and IL-12 (clone C17.8) depletion antibodies were purchased from Bio X Cell and Biolegend. Other depletion antibodies, anti-CD4 (clone GK1.5), anti-CD8 (clone 53.6.7), and anti-NK1.1 (clone PK136) were produced and purified from each of hybridoma cell lines. Antibodies were administered intraperitoneally (i.p) in doses of 500 µg for IL-12 and TNFα depletion and 100 µg for CD4 + cells, CD8 + cells, NK cells, and IFNAR1 depletion.
Flow cytometry
For cell-surface molecules, cell samples were stained with fluorescent dye-conjugated mAb against selected markers on ice. Then, cells were harvested and stained with 21 7-AAD, anti-CD4, -CD8, -NK1.1, CD11c, and B220 (BD Bioscience). Data were acquired by FACSCant II and analyzed with FlowJo software.
Generation of Fc fusion protein
HEK293T cells were transfected with the expression construct using polyethylenimine (PEI). Two days after transfection, conditioned medium was collected, centrifuged, passed through a 0.45-µm filter membrane. Fc fusion protein was purified by protein
A-Sepharose 4 Fast Flow (Amersham Biosciences). After dialysis against PBS, purity
was checked by SDS-PAGE and CBB staining.
RT-PCR
First-stranded cDNA was synthesized using Transcriptor Reverse Transcriptase (Roche).
PCR reactions were carried out in a total volume of 10 µl containing 1 µl of first strand cDNA using ExTaq (Takara). RT-PCR was carried out as described (15) . Primers 
Cytokine and chemokine determinations
For analysis of microglia produced cytokine and chemokine profile, the supernatants were obtained from primary microglia culture 24h after stimulation by 20 μg/ml of 
Microarray hybridization and data processing
Total RNA was extracted from mouse microglia treated with 20 μg/ml of Ecrg4 fragments for 3h using the TRIzol Plus RNA Purification System (Invitrogen). Purified RNA was then amplified and labeled with Cyanine 3 using the one-color Agilent Low
Input Quick Amp Labeling Kit (Agilent Technologies) following the manufacturer's instructions. Labeled cRNAs were fragmented and hybridized to the Agilent mouse GE 8x60K Microarray. After washing, microarrays were scanned with an Agilent DNA microarray scanner. Intensity values for each scanned feature were quantified using Agilent feature extraction software, which performed background subtractions.
Normalization was achieved using Agilent GeneSpring GX version13.1. After normalization, hierarchical sample clustering of the expressed genes was performed with the Euclidean distance and Ward'slinkage methods (Agilent GeneSpring GX).
TCGA analysis
25
Each 27 microarray data of human GBM and LGG were obtained from The Cancer
Genome Atlas (TCGA) and analyzed for the expression levels of ecrg4, ifna5, ifna14
and ifnb1.
Statistical analyses
Statistical analyses were carried out using GraphPad Prism or Microsoft Excel software.
Data were presented if not indicated elsewhere as mean ± SD. 
